BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35394496)

  • 21. Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders.
    Midic D; Rinke J; Perner F; Müller V; Hinze A; Pester F; Landschulze J; Ernst J; Gruhn B; Matziolis G; Heidel FH; Hochhaus A; Ernst T
    Leukemia; 2020 Aug; 34(8):2198-2205. PubMed ID: 32457355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal Stromal Cell Senescence Induced by
    Mistry JJ; Young KA; Colom Díaz PA; Maestre IF; Levine RL; Trowbridge JJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 38585779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
    Kusne Y; Fernandez J; Patnaik MM
    Semin Hematol; 2021 Oct; 58(4):226-229. PubMed ID: 34802544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
    Haybar H; Shahrabi S; Ghanavat M; Khodadi E
    J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.
    Weinstock JS; Gopakumar J; Burugula BB; Uddin MM; Jahn N; Belk JA; Bouzid H; Daniel B; Miao Z; Ly N; Mack TM; Luna SE; Prothro KP; Mitchell SR; Laurie CA; Broome JG; Taylor KD; Guo X; Sinner MF; von Falkenhausen AS; Kääb S; Shuldiner AR; O'Connell JR; Lewis JP; Boerwinkle E; Barnes KC; Chami N; Kenny EE; Loos RJF; Fornage M; Hou L; Lloyd-Jones DM; Redline S; Cade BE; Psaty BM; Bis JC; Brody JA; Silverman EK; Yun JH; Qiao D; Palmer ND; Freedman BI; Bowden DW; Cho MH; DeMeo DL; Vasan RS; Yanek LR; Becker LC; Kardia SLR; Peyser PA; He J; Rienstra M; Van der Harst P; Kaplan R; Heckbert SR; Smith NL; Wiggins KL; Arnett DK; Irvin MR; Tiwari H; Cutler MJ; Knight S; Muhlestein JB; Correa A; Raffield LM; Gao Y; de Andrade M; Rotter JI; Rich SS; Tracy RP; Konkle BA; Johnsen JM; Wheeler MM; Smith JG; Melander O; Nilsson PM; Custer BS; Duggirala R; Curran JE; Blangero J; McGarvey S; Williams LK; Xiao S; Yang M; Gu CC; Chen YI; Lee WJ; Marcus GM; Kane JP; Pullinger CR; Shoemaker MB; Darbar D; Roden DM; Albert C; Kooperberg C; Zhou Y; Manson JE; Desai P; Johnson AD; Mathias RA; ; Blackwell TW; Abecasis GR; Smith AV; Kang HM; Satpathy AT; Natarajan P; Kitzman JO; Whitsel EA; Reiner AP; Bick AG; Jaiswal S
    Nature; 2023 Apr; 616(7958):755-763. PubMed ID: 37046083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in understanding the molecular basis of clonal hematopoiesis.
    Alagpulinsa DA; Toribio MP; Alhallak I; Shmookler Reis RJ
    Trends Mol Med; 2022 May; 28(5):360-377. PubMed ID: 35341686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell origin-dependent cooperativity of mutant Dnmt3a and Npm1 in clonal hematopoiesis and myeloid malignancy.
    SanMiguel JM; Eudy E; Loberg MA; Miles LA; Stearns T; Mistry JJ; Rauh MJ; Levine RL; Trowbridge JJ
    Blood Adv; 2022 Jun; 6(12):3666-3677. PubMed ID: 35413095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Functional role of DNMT3A mutation in acute myeloid leukemia].
    Koya J; Kurokawa M
    Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients.
    Zhang CRC; Nix D; Gregory M; Ciorba MA; Ostrander EL; Newberry RD; Spencer DH; Challen GA
    Exp Hematol; 2019 Dec; 80():36-41.e3. PubMed ID: 31812712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis.
    SanMiguel JM; Young K; Trowbridge JJ
    Exp Hematol; 2020 Nov; 91():1-9. PubMed ID: 32991978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related micro-environmental changes as drivers of clonal hematopoiesis.
    Bacharach T; Kaushansky N; Shlush LI
    Curr Opin Hematol; 2024 Mar; 31(2):53-57. PubMed ID: 38133628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
    Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
    Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
    Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
    Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis.
    Avagyan S; Henninger JE; Mannherz WP; Mistry M; Yoon J; Yang S; Weber MC; Moore JL; Zon LI
    Science; 2021 Nov; 374(6568):768-772. PubMed ID: 34735227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dnmt3a is essential for hematopoietic stem cell differentiation.
    Challen GA; Sun D; Jeong M; Luo M; Jelinek J; Berg JS; Bock C; Vasanthakumar A; Gu H; Xi Y; Liang S; Lu Y; Darlington GJ; Meissner A; Issa JP; Godley LA; Li W; Goodell MA
    Nat Genet; 2011 Dec; 44(1):23-31. PubMed ID: 22138693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
    Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
    BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHIP: is clonal hematopoiesis a surrogate for aging and other disease?
    Gondek LP
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):384-389. PubMed ID: 34889429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
    Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
    J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.